Notify me when Prosight Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | Common Stock, $0.0001 par value per share | 9.9% | $15.6M | 6.54M | Prosight Management, LP | 30 Sep 2025 | ||
| ADCT | ADC Therapeutics SA | Common Shares | 5.8% | $28.8M | 7.2M | Prosight Management, LP | 30 Sep 2025 | ||
| OKUR | OnKure Therapeutics, Inc. | Class A Common Stock, par value $0.0001 per share | 5.8% | $2.21M | 746K | Prosight Management, LP | 24 Nov 2025 | ||
| MGTX | MeiraGTx Holdings plc | Ordinary Shares, $0.00003881 par value per share | 5.4% | $22.1M | 4.36M | W. Lawrence Hawkins | 31 Mar 2025 | ||
| VINC | Vincerx Pharma, Inc. | Common Stock, $0.0001 par value per share | 4.99% | $30.2K | 112K | Prosight Management, LP | 31 Dec 2024 | ||
| MURA | Mural Oncology plc | Ordinary Shares, nominal value $0.01 per share | 0% | $0 | -$1.86M | 0 | -100% | Prosight Management, LP | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|